NCT01790503: A reported trial by Daiichi Sankyo
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT01790503 |
|---|---|
| Title | An Open Label Phase 1b/2 Study of Orally Administered PLX3397 in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | July 18, 2013 |
| Completion date | Nov. 3, 2017 |
| Required reporting date | Nov. 3, 2020, midnight |
| Actual reporting date | Aug. 22, 2019 |
| Date last checked at ClinicalTrials.gov | April 22, 2026 |
| Days late | None |